HomeVNDA • NASDAQ
add
Vanda Pharmaceuticals Inc.
Previous close
$3.93
Day range
$3.89 - $4.24
Year range
$3.81 - $6.75
Market cap
245.17M USD
Avg Volume
630.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 50.04M | 5.43% |
Operating expense | 87.55M | 64.39% |
Net income | -29.49M | -611.38% |
Net profit margin | -58.94 | -574.37% |
Earnings per share | — | — |
EBITDA | -39.04M | -456.91% |
Effective tax rate | 21.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 340.91M | -13.51% |
Total assets | 631.94M | -3.18% |
Total liabilities | 120.52M | 10.89% |
Total equity | 511.42M | — |
Shares outstanding | 58.93M | — |
Price to book | 0.45 | — |
Return on assets | -15.93% | — |
Return on capital | -19.10% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -29.49M | -611.38% |
Cash from operations | -33.15M | -537.93% |
Cash from investing | 43.90M | 340.98% |
Cash from financing | -1.32M | — |
Net change in cash | 9.48M | 188.91% |
Free cash flow | -20.06M | -951.46% |
About
Founded
2002
Headquarters
Website
Employees
368
